Special Interest Group in Cancer
- To identify existing oncology data sources and professional and research networks that may be considered in peri-approval and observational research;
- To identify issues unique to cancer pharmacoepidemiology, and to explore methodological approaches to address these issues; and
- To serve as a resource to the ISPE membership by providing expertise in cancer pharmacoepidemiology and educational content in the area.
- Oncology SIG will be a multi-disciplinary SIG whose goal is to create, facilitate and promote a platform for sharing relevant genomic, pharmacological, clinical, and methodological knowledge.
Please visit our ISPE Community for the latest SIG news, upcoming meetings, membership, documents library, connecting with SIG members and leaders, and more. An account is needed to access the community and join it.